Today the FDA approved the first targeted therapy to treat patients with a painful complication of sickle cell disease called vaso-occlusive crisis https://go.usa.gov/xpKhr pic.twitter.com/uSfKXE0haC
Today the FDA approved the first targeted therapy to treat patients with a painful complication of sickle cell disease called vaso-occlusive crisis https://go.usa.gov/xpKhr pic.twitter.com/uSfKXE0haC
Source: Food and Drug Adminstration (FDA): CDRHNew - Category: Medical Devices Authors: ( at FDAMedia) Source Type: news
More News: Medical Devices | Sickle Cell Anemia